Want to see CYTOF full AI Analyst Report?
Altamira Therapeutics (CYTOF) Financial Statements
Altamira Therapeutics Financial Overview
Altamira Therapeutics's market cap is currently $404.65K. The company's EPS TTM is $-228.63; its P/E ratio is -0.13; Altamira Therapeutics has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 305.62K | $ 63.88K | $ 174.47K | $ -56.00K |
| Gross Profit | $ 0.00 | $ -1.14M | $ -2.18M | $ 174.47K | $ -56.00K |
| Operating Income | $ -5.92M | $ -26.13M | $ -17.10M | $ -5.28M | $ -7.26M |
| EBITDA | $ -1.35M | $ -17.64M | $ -6.72M | $ -5.26M | $ -7.24M |
| Net Income | $ -7.27M | $ -26.53M | $ -17.39M | $ -8.20M | $ -6.63M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 617.41K | $ 15.39K | $ 984.19K | $ 11.26M | $ 1.38M |
| Total Assets | $ 7.69M | $ 6.30M | $ 18.84M | $ 20.80M | $ 9.23M |
| Total Debt | $ 99.66K | $ 6.33M | $ 575.74K | $ 523.92K | $ 0.00 |
| Net Debt | $ -517.75K | $ 6.32M | $ -408.45K | $ -10.73M | $ -1.38M |
| Total Liabilities | $ 1.24M | $ 14.62M | $ 6.13M | $ 4.03M | $ 3.19M |
| Stockholders' Equity | $ 6.46M | $ -8.31M | $ 12.70M | $ 16.77M | $ 6.04M |
| Cash Flow | |||||
| Free Cash Flow | $ -11.51M | $ -10.83M | $ -17.00M | $ -7.16M | $ -11.41M |
| Operating Cash Flow | $ -11.51M | $ -8.68M | $ -13.67M | $ -4.84M | $ -8.39M |
| Investing Cash Flow | $ 1.44M | $ -2.14M | $ -3.51M | $ -2.31M | $ -3.00M |
| Financing Cash Flow | $ 10.62M | $ 9.83M | $ 6.61M | $ 16.96M | $ 7.38M |
Currency in CHF